Chaperon Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-12-2024
- Paid Up Capital ₹ 0.10 M
as on 04-12-2024
- Company Age 11 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.74 M
as on 04-12-2024
About Chaperon Biotech
The Company is engaged in the Education & Learing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.74 M.
Gyaneshwar Patel, Saurabh Singh, and Suneeta Dubey serve as directors at the Company.
- CIN/LLPIN
U24233UP2013PTC056258
- Company No.
056258
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Apr 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Kanpur Nagar, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Chaperon Biotech Private Limited offer?
Chaperon Biotech Private Limited offers a wide range of products and services, including Mosquito & Insect Repellent, Mosquito Repellent, FRP Lining, PU & Powder Coatings, Automotive Paints and Coatings, Medical Laboratory Instruments, Corona Test Kit.
Who are the key members and board of directors at Chaperon Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gyaneshwar Patel  | Director | 17-Apr-2013 | Current |
| Saurabh Singh | Director | 06-Sep-2016 | Current |
| Suneeta Dubey | Director | 27-Jun-2023 | Current |
Financial Performance of Chaperon Biotech.
Chaperon Biotech Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Chaperon Biotech?
In 2017, Chaperon Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ameliorate Bio Energy Farmer Producer Company LimitedActive 5 years 7 monthsGyaneshwar Patel is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Jul 2018 | ₹0.50 M | Open |
Bank Of Baroda Creation Date: 29 Sep 2014 | ₹0.24 M | Open |
How Many Employees Work at Chaperon Biotech?
Unlock and access historical data on people associated with Chaperon Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chaperon Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chaperon Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
